Efficacy of oral etoposide in patients with platinum and taxane-resistant intensively pretreated ovarian cancer

被引：0
|
作者：
Makhnova, Elena V. [1 ]
Gershanovich, Michael L. [1 ]
机构：
[1] NN Petrov Oncol Res Inst, St Petersburg, Russia
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：128 / 129
页数：2
相关论文
共 50 条
  • [21] Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer
    Galletti, Giuseppe
    Zhang, Chao
    Gjyrezi, Ada
    Cleveland, Kyle
    Zhang, Jiaren
    Powell, Sarah
    Thakkar, Prashant, V
    Betel, Doron
    Shah, Manish A.
    Giannakakou, Paraskevi
    CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3771 - 3783
  • [22] Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
    Nagano, Hiroaki
    Tachibana, Yasunari
    Kawakami, Megumi
    Ueno, Mariko
    Morita, Yoshihiro
    Muraoka, Mitsue
    Takagi, Koichiro
    CASE REPORTS IN ONCOLOGY, 2016, 9 (01): : 195 - 204
  • [23] Doxorubicin hydrochloride and bevacizumab for the patients with platinum-taxane resistant ovarian cancer
    Ota, T.
    Sugimori, Y.
    Fujino, K.
    Ujihira, T.
    Kusunoki, S.
    Kimura, M.
    Terao, Y.
    Ogishima, D.
    Takeda, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (06) : 889 - 893
  • [24] ORAL ETOPOSIDE IS ACTIVE AGAINST PLATINUM-RESISTANT EPITHELIAL OVARIAN-CANCER
    HOSKINS, PJ
    SWENERTON, KD
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 60 - 63
  • [25] Efficacy and safety of etoposide in patients with platinum-pretreated metastatic or recurrent urothelial cancer
    Kondoh, Chihiro
    Kawada, Kenji
    Nagase, Michitaka
    Kato, Hisano
    Funahashi, Yoriko
    Nakano, Yasuyuki
    ANNALS OF ONCOLOGY, 2015, 26 : 144 - 144
  • [26] Management of Castration-Resistant, Taxane-Resistant Prostate Cancer
    Beer, Tomasz M.
    ONCOLOGY-NEW YORK, 2017, 31 (08): : 633 - 636
  • [27] Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers
    Coleman, RL
    Broaddus, RR
    Bodurka, DC
    Wolf, JK
    Burke, TW
    Kavanagh, JJ
    Levenback, CF
    Gershenson, DM
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 126 - 131
  • [28] Conversion of platinum-taxane resistant to sensitive ovarian cancer with a non-platinum-taxane regimen
    Tate, Shinichi
    Niahikimi, Kyoko
    Usul, Hirokazu
    Mitsuhashi, Akira
    Shozu, Makio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane -: Results from a multicenter phase I/II study
    Gronlund, B
    Engelholm, SA
    Horvath, G
    Mäenpää, J
    Ridderheim, M
    CANCER, 2005, 103 (07) : 1388 - 1396
  • [30] Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers
    Goto, Tomoko
    Takano, Masashi
    Ohishi, Rie
    Iwasa, Norihiro
    Shimizu, Motohiro
    Hasegawa, Kosei
    Nagao, Shoji
    Fujiwara, Keiichi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (04) : 764 - 768
12345